logo
Plus   Neg
Share
Email

Santos Q3 Production Flat; Narrows FY Production And Sales Volumes Guidance

Santos Ltd. (STOSF.PK,SSLTY.PK,STO.AX) reported that its third quarter production was 15 million barrels of oil equivalent or mmboe, same with last year. Sales revenue grew 22.7% year-over-year to US$973 million, including record quarterly LNG revenues of US$405 million.

Santos Managing Director and Chief Executive Officer Kevin Gallagher said, "Santos' third quarter results serve to highlight the benefits of a cash generative core asset portfolio and our low-cost, disciplined Operating Model. During the quarter we paid our first dividend in two and a half years and achieved our net debt target of $2 billion more than a year ahead of plan."

Santos said it is now positioned for growth with a number of upstream brownfield development opportunities leveraging existing infrastructure positions across each of our five core assets and is targeting production of more than 100 mmboe by 2025, almost doubling current levels of production.

Santos raised the lower end of its 2018 production outlook to 56-58 mmboe from 55-58 mmboe. The sales volume is expected to be in the range of 74-76 mmboe compared to the prior outlook of 72-76 mmboe.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. auto safety regulator has opened an investigation into about 115,000 Tesla electric vehicles over a front suspension safety issue. The probe covers 2015 through 2017 Model S sedans and 2016 through 2017 Model X SUVs. The investigation comes after Tesla reportedly started a recall over the issue for vehicles in China. Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform
Follow RTT